603 related articles for article (PubMed ID: 12496938)
21. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
Vickroy TW; Johnson KM
J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
[TBL] [Abstract][Full Text] [Related]
22. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.
Jentsch JD; Tran A; Taylor JR; Roth RH
Psychopharmacology (Berl); 1998 Jul; 138(1):89-95. PubMed ID: 9694531
[TBL] [Abstract][Full Text] [Related]
23. Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats.
Quarta D; Large CH
J Psychopharmacol; 2011 Dec; 25(12):1703-11. PubMed ID: 21041417
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine.
Fejgin K; Pålsson E; Wass C; Svensson L; Klamer D
Neuropsychopharmacology; 2008 Jul; 33(8):1874-83. PubMed ID: 17895915
[TBL] [Abstract][Full Text] [Related]
25. Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction.
Nakao K; Jeevakumar V; Jiang SZ; Fujita Y; Diaz NB; Pretell Annan CA; Eskow Jaunarajs KL; Hashimoto K; Belforte JE; Nakazawa K
Schizophr Bull; 2019 Jan; 45(1):138-147. PubMed ID: 29394409
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
Giorgi O; Piras G; Lecca D; Corda MG
Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
[TBL] [Abstract][Full Text] [Related]
27. The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat.
Turgeon SM; Case LC
Brain Res; 2001 Jan; 888(2):302-305. PubMed ID: 11150488
[TBL] [Abstract][Full Text] [Related]
28. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Del Arco A; Segovia G; Mora F
Psychopharmacology (Berl); 2008 Dec; 201(3):325-38. PubMed ID: 18751970
[TBL] [Abstract][Full Text] [Related]
29. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
[TBL] [Abstract][Full Text] [Related]
30. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
[TBL] [Abstract][Full Text] [Related]
31. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
[TBL] [Abstract][Full Text] [Related]
32. Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801.
Mele A; Fontana D; Pert A
Synapse; 1997 Jul; 26(3):218-24. PubMed ID: 9183811
[TBL] [Abstract][Full Text] [Related]
33. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Jentsch JD; Wise A; Katz Z; Roth RH
Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014
[TBL] [Abstract][Full Text] [Related]
34. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
35. Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.
Kohli S; King MV; Williams S; Edwards A; Ballard TM; Steward LJ; Alberati D; Fone KCF
Neuropsychopharmacology; 2019 Jan; 44(2):295-305. PubMed ID: 30120410
[TBL] [Abstract][Full Text] [Related]
36. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
37. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
Auclair A; Blanc G; Glowinski J; Tassin JP
J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
[TBL] [Abstract][Full Text] [Related]
38. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
[TBL] [Abstract][Full Text] [Related]
39. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
Tan SE
Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
[TBL] [Abstract][Full Text] [Related]
40. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.
Jentsch JD; Dazzi L; Chhatwal JP; Verrico CD; Roth RH
Neurosci Lett; 1998 Dec; 258(3):175-8. PubMed ID: 9885959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
